BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2640480)

  • 1. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
    Segal-Eiras A; Croce MV; Ramos GS; Córsico B
    Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of circulating immune complexes in cutaneous diseases associated with immune disorders.
    Fernández Bussy R; Crisci CD; Fiorenza G; Bertoya N
    Allergol Immunopathol (Madr); 1990; 18(1):47-52. PubMed ID: 2143349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
    Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
    Hori MT; Abrass CK
    J Immunol; 1990 May; 144(10):3849-55. PubMed ID: 2185315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence and structure of circulating immune complexes in patients with prostate tumors.
    Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
    Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of components of IC purified from human sera. II. Demonstration of mycobacterial antigens in immune complexes isolated from sera of lepromatous patients.
    Chakrabarty AK; Maire M; Saha K; Lambert PH
    Clin Exp Immunol; 1983 Feb; 51(2):225-31. PubMed ID: 6340869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of circulating immune complexes in cystic fibrosis.
    Moss RB; Hsu YP
    Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Composition of circulating immune complexes in acute toxoplasmosis].
    Gladkova SV; Bormotov NI; Dedkova LM; Belanov EF; Golubiatnikova AV; Kiseleva ZF; Reshetnikov SS
    Med Parazitol (Mosk); 2000; (4):15-8. PubMed ID: 11210407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K; Nagashima H; Tsuji T
    Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antibody-dependent, cell-mediated cytotoxicity by serum from lepromatous leprosy patients.
    de la Barrera SS; Sasiain MC; Geffner J; Isturiz MA; Segal-Eiras A; de Bracco MM
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):218-24. PubMed ID: 4020209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in pulmonary tuberculosis.
    Ashtekar MD; Samuel AM
    J Clin Lab Immunol; 1985 Oct; 18(2):91-5. PubMed ID: 3935794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.